Associated Papers
Genomic profiling identifies GPC5 amplification in association with sarcomatous transformation in a subset of uterine carcinosarcomas.
Chui MH et al.
The Journal of Pathology. Clinical Research, 2018
29416878 (PubMed )
Supplement: CJP2-4-69-s001.xls › Sheet1
High prevalence of TP53 mutations is associated with poor survival and an EMT signature in gliosarcoma patients.
Cho SY et al.
Experimental & Molecular Medicine, 2017
28408749 (PubMed )
Supplement: emm20179x1.xlsx › Table_S9
Genomic profiling of multiple sequentially acquired tumor metastatic sites from an "exceptional responder" lung adenocarcinoma patient reveals extensive genomic heterogeneity and novel somatic variants driving treatment response.
Biswas R et al.
Cold Spring Harbor Molecular Case Studies, 2016
27900369 (PubMed )
Supplement: supp_mcs.a001263_SuppTable_S2.xlsx › Supplementary_Table_S2_A
Genomic differences between pure ductal carcinoma in situ and synchronous ductal carcinoma in situ with invasive breast cancer.
Kim SY et al.
Oncotarget, 2015
25831047 (PubMed )
Supplement: oncotarget-06-7597-s004.xlsx › Table_S3
Select a paper to view details